Home›Search›Blood Neoplasia

Blood Neoplasia

Elsevier · United States

eISSN2950-3280

SJR Q1✓ Scopus / SJR✓ DOAJ✓ Open Access

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 25% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

1.181

H-Indexi

Aims & Scope✦ Inferred from recent articles

Blood Neoplasia focuses on hematologic malignancies, including leukemias and lymphomas. Research covers therapeutic strategies such as targeted therapies (e.g., Menin inhibitors, B-cell lymphoma 2 inhibitors), immunotherapy (e.g., CAR T-cell therapy, PD-1 inhibitors), and novel drug combinations. The journal also investigates biomarkers like circulating tumor DNA (ctDNA) for disease monitoring and prognostic assessment, and explores the molecular pathogenesis of these cancers, including genomic alterations and resistance mechanisms.

AI-summarised from recent articles · verify on publisher page →

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published—

StatusActive

Total Publications—

Visit Journal Website

Submission Info

Peer ReviewAnonymous peer review

OA LicenseCC BY, CC BY-NC-ND

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

8/11 · 73%

✅

Do you know the journal / publisher?

Elsevier

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2950-3280

✅

Indexed in a trusted database?

Scopus, DOAJ, PubMed

✅

Peer review process documented?

Anonymous peer review

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HematologyQ1

OncologyQ2

Subject Classification

Research Topics (OpenAlex)

Acute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsMultiple Myeloma Research and TreatmentsAcute Lymphoblastic Leukemia researchCAR-T cell therapy researchMyeloproliferative Neoplasms: Diagnosis and TreatmentProtein Degradation and InhibitorsRetinoids in leukemia and cellular processes

Frequently asked questions about Blood Neoplasia

Is Blood Neoplasia a predatory journal?

PubScope has no integrity flags on record for Blood Neoplasia: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Blood Neoplasia?

Blood Neoplasia is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 1.181.

Is Blood Neoplasia indexed in Scopus and Web of Science?

Blood Neoplasia is indexed in Scopus, DOAJ.